Biotinylated Recombinant SARS-CoV-2 Spike S1 Protein (C-His-Avi tag)
Product Description
Biotinylated recombinant SARS-CoV-2 Spike S1 Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Gln14-Arg683) of SARS-CoV-2 Spike S1 fused with His tag and Avi tag at the C-terminal.
Usage Statement
Research use only, not for direct human use.
Key Applications
ELISA, SPR, SDS-PAGE, Western Blotting, Immunoprecipitation, Immune Blocking, Binding Assay
Specifications
SKU | 08L100006 |
Alternate Names | S protein; Spike glycoprotein; S glycoprotein |
Bioreactivity | Immobilized Biotinylated SARS-CoV-2 Spike S1 at 0.5 μg/mL (100 μL/Well). Dose response curve for Human ACE2 with the EC50 of 16.1 ng/mL determined by ELISA. |
Concentration | 1 mg/mL if dissolve in 100 µL of ddH20 or biological buffer |
Conjugate | Biotinylated |
Endotoxin | < 1 EU/μg of the protein by LAL method. |
Formulation Details | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.3-7.4. |
Grade | Molecular Grade |
Host | Expi293 cells |
Pack Size | 100 µg |
Preparation Method | Affinity Chromatography |
Protein Tag | C-His-Avi |
Purity | >97% by Tris-Bis PAGE ;> 95% by SEC-HPLC |
Solubility | Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Addition of a carrier protein (such as 0.05-0.1% BSA) is recommended for long-term storage. |
Species Reactivity | Human, Mouse, Rat |
Storage | -20° |
Uniprot Number | QHD43416.1 |
Usage Statement | Research use only, not for direct human use. |
Documents
Certificate of Analysis (COA)
Datasheet
Datasheet
English (United States)
Safety Data Sheets
English (United States)
Brochures
Brochures
English (United States)